Open-Label Extension Study of BBP-418 (Ribitol) for LGMD2I/R9
Open-Label Extension Study of BBP-418 (Ribitol) for LGMD2I/R9
Active, not recruiting · NCT07678775 · Registry updated 2026-07-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Open-Label Extension Study of BBP-418 (Ribitol) for LGMD2I/R9 | autosomal recessive limb-girdle muscular dystrophy type 2I | Active, not recruiting | Phase 3 | 2026-07-02 | NCT07678775 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ML Bio Solutions, Inc. | 3 |
20 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.